Investing.com - Patterson reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Patterson announced earnings per share of $0.58 on revenue of $1.55B. Analysts polled by Investing.com anticipated EPS of $0.5125 on revenue of $1.5B.
Patterson shares are up 9% from the beginning of the year, still down 12.26% from its 52 week high of $36.88 set on January 27. They are outperforming the Nasdaq which is up 3.65% from the start of the year.
Patterson follows other major Healthcare sector earnings this month
Patterson's report follows an earnings beat by AbbVie on February 3, who reported EPS of $2.92 on revenue of $13.86B, compared to forecasts EPS of $2.85 on revenue of $13.7B.
Pfizer had missed expectations on February 2 with fourth quarter EPS of $0.42 on revenue of $11.68B, compared to forecast for EPS of $0.4952 on revenue of $11.47B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar